FRAMINGHAM, Mass. — Federal regulators said Thursday that they have found contamination in more drugs made by a pharmacy tied to a deadly meningitis outbreak.
The U.S. Food and Drug Administration said it doesn’t yet know the significance of the bacterial contamination discovered in recalled New England Compounding Center products. Some of the bacteria found are rarely cited as a cause of disease in humans. And no NECC products have been tied to reports of infection from the bacteria, the FDA said.
But the agency said the findings bolster concerns about a lack of sterility at the now-closed company. Investigators there have found standing water from a leaking boiler, filthy floor mats and records indicating drugs were shipped before sterility tests were returned.
The FDA test results were released hours after an announcement Thursday by U.S. Rep. Ed Markey that he’ll introduce legislation to strengthen the federal oversight over compounding pharmacies, which custom-mix solutions that generally aren’t commercially available. They aren’t regulated by the FDA.
Markey announced his legislation in a parking lot outside the NECC building in Framingham. A tainted steroid made there, and used to treat back pain, has caused a fungal meningitis outbreak that has spread to 19 states, sickening 377, 28 of whom have died.
